These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26592445)

  • 21. Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation.
    Cable JM; Reinoso-Vizcaino NM; White RE; Luftig MA
    PLoS Pathog; 2024 Jul; 20(7):e1011950. PubMed ID: 39083560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.
    Park GB; Kim D; Park SJ; Lee HK; Kim JH; Kim YS; Park SG; Choi IH; Yoon SH; Lee YJ; Paeng S; Hur DY
    Int J Mol Med; 2015 Dec; 36(6):1464-78. PubMed ID: 26498453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
    Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
    J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
    J Virol; 2020 May; 94(10):. PubMed ID: 32132242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs.
    Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S
    Cancer Lett; 2013 Sep; 337(2):193-9. PubMed ID: 23684926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells.
    Jiang S; Zhou H; Liang J; Gerdt C; Wang C; Ke L; Schmidt SCS; Narita Y; Ma Y; Wang S; Colson T; Gewurz B; Li G; Kieff E; Zhao B
    Cell Host Microbe; 2017 Oct; 22(4):561-573.e4. PubMed ID: 29024646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.
    Tierney RJ; Nagra J; Rowe M; Bell AI; Rickinson AB
    J Virol; 2015 Mar; 89(5):2483-93. PubMed ID: 25540367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
    Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
    Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
    Webster-Cyriaque J; Middeldorp J; Raab-Traub N
    J Virol; 2000 Aug; 74(16):7610-8. PubMed ID: 10906215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.
    Wang L; Howell MEA; Sparks-Wallace A; Zhao J; Hensley CR; Nicksic CA; Horne SR; Mohr KB; Moorman JP; Yao ZQ; Ning S
    mBio; 2021 Oct; 12(5):e0109721. PubMed ID: 34488443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain.
    Danve C; Decaussin G; Busson P; Ooka T
    Virology; 2001 Sep; 288(2):223-35. PubMed ID: 11601894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
    Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
    J Virol; 2018 May; 92(9):. PubMed ID: 29467311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.